• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体内表达短发夹RNA。

Expressing short hairpin RNAs in vivo.

作者信息

Snøve Ola, Rossi John J

机构信息

Division of Molecular Biology, Beckman Research Institute of the City of Hope, Duarte, California 91010, USA.

出版信息

Nat Methods. 2006 Sep;3(9):689-95. doi: 10.1038/nmeth927.

DOI:10.1038/nmeth927
PMID:16929313
Abstract

Promoter-based expression of short hairpin RNAs (shRNAs) may in principle provide stable silencing of genes in any tissue. As for all approaches that require transgene expression, safe delivery is the biggest obstacle, but toxicity can also occur via expression of the sequence itself. Innate immunity mechanisms can be triggered by expressed hairpin RNAs, critical cellular factors can be saturated, and genes other than the intended target can be silenced. Nevertheless, shRNAs constitute a valuable tool for in vivo research and have great therapeutic potential if the challenges with delivery and side effects are appropriately addressed.

摘要

基于启动子的短发夹RNA(shRNA)表达原则上可在任何组织中实现基因的稳定沉默。对于所有需要转基因表达的方法而言,安全递送是最大的障碍,但毒性也可能通过序列本身的表达而产生。表达的发夹RNA可触发天然免疫机制,关键细胞因子可能会饱和,并且非预期靶标的其他基因也可能被沉默。尽管如此,如果能够妥善解决递送和副作用方面的挑战,shRNA仍是体内研究的宝贵工具,具有巨大的治疗潜力。

相似文献

1
Expressing short hairpin RNAs in vivo.在体内表达短发夹RNA。
Nat Methods. 2006 Sep;3(9):689-95. doi: 10.1038/nmeth927.
2
Short hairpin RNAs induced RNA interference in human cells.短发夹RNA在人类细胞中诱导RNA干扰。
Ai Zheng. 2003 Jun;22(6):566-70.
3
Drosophila U6 promoter-driven short hairpin RNAs effectively induce RNA interference in Schneider 2 cells.果蝇U6启动子驱动的短发夹RNA可有效诱导施奈德2细胞中的RNA干扰。
Biochem Biophys Res Commun. 2005 Jun 17;331(4):1163-70. doi: 10.1016/j.bbrc.2005.03.240.
4
Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.通过腺病毒介导的抗MDR1短发夹RNA和核酶递送克服经典多药耐药表型。
Int J Oncol. 2007 Aug;31(2):419-30.
5
Viral delivery of recombinant short hairpin RNAs.重组短发夹RNA的病毒递送
Methods Enzymol. 2005;392:145-73. doi: 10.1016/S0076-6879(04)92009-5.
6
Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing.腺病毒介导的RNA干扰对多药耐药蛋白2基因沉默小鼠模型中内源性微小RNA的影响。
J Virol. 2006 Dec;80(24):12236-47. doi: 10.1128/JVI.01205-06. Epub 2006 Oct 4.
7
RNA interference by small hairpin RNAs synthesised under control of the human 7S K RNA promoter.在人7S K RNA启动子控制下合成的小发夹RNA介导的RNA干扰。
Biol Chem. 2004 Sep;385(9):791-4. doi: 10.1515/BC.2004.103.
8
In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.通过靶向电介导的小干扰RNA递送实现实体瘤的体内基因沉默
Gene Ther. 2007 May;14(9):752-9. doi: 10.1038/sj.gt.3302920. Epub 2007 Mar 8.
9
Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.非病毒载体介导的RNA干扰:其基因沉默特性及实现基于RNA干扰的基因治疗的重要因素。
Adv Drug Deliv Rev. 2009 Jul 25;61(9):760-6. doi: 10.1016/j.addr.2009.04.006. Epub 2009 Apr 20.
10
Knock-down of gene expression in hematopoietic cells.造血细胞中基因表达的敲低。
Methods Mol Biol. 2009;506:207-19. doi: 10.1007/978-1-59745-409-4_15.

引用本文的文献

1
Dual VEGF-Targeting Strategy Via AAV2-Delivered sFLT-1 and shVEGF for Retinal Neovascularization Therapy.通过腺相关病毒2型递送的可溶性血管内皮生长因子受体1和血管内皮生长因子短发夹RNA的双重血管内皮生长因子靶向策略用于视网膜新生血管治疗
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):37. doi: 10.1167/iovs.66.11.37.
2
Nanocarriers for cutting-edge cancer immunotherapies.用于前沿癌症免疫疗法的纳米载体。
J Transl Med. 2025 Apr 16;23(1):447. doi: 10.1186/s12967-025-06435-0.
3
Lipid nanomaterials-based RNA therapy and cancer treatment.基于脂质纳米材料的RNA疗法与癌症治疗。
Acta Pharm Sin B. 2023 Mar;13(3):903-915. doi: 10.1016/j.apsb.2022.10.004. Epub 2022 Oct 11.
4
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy.外泌体介导的核酸递送至癌症治疗的最新进展。
J Nanobiotechnology. 2022 Jun 14;20(1):279. doi: 10.1186/s12951-022-01472-z.
5
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia.在慢性期慢性髓性白血病中,去调节的刺猬信号通路信号传导被平滑拮抗剂LDE225(索尼德吉)抑制。
Sci Rep. 2016 May 9;6:25476. doi: 10.1038/srep25476.
6
Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury.利用慢病毒 miRNA 在体内靶向肺血管内皮细胞的 HO-1 调节氧化损伤时的细胞凋亡和自噬。
FASEB J. 2013 Oct;27(10):4041-58. doi: 10.1096/fj.13-231225. Epub 2013 Jun 14.
7
MicroRNAs: potential mediators and biomarkers of diabetic complications.微小 RNA:糖尿病并发症的潜在介质和生物标志物。
Free Radic Biol Med. 2013 Sep;64:85-94. doi: 10.1016/j.freeradbiomed.2013.06.009. Epub 2013 Jun 12.
8
MicroRNAs and diabetic complications.微小 RNA 与糖尿病并发症。
J Cardiovasc Transl Res. 2012 Aug;5(4):413-22. doi: 10.1007/s12265-012-9368-5. Epub 2012 May 3.
9
Role of microRNAs in diabetes and its cardiovascular complications.microRNAs 在糖尿病及其心血管并发症中的作用。
Cardiovasc Res. 2012 Mar 15;93(4):583-93. doi: 10.1093/cvr/cvr300. Epub 2011 Nov 7.
10
Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity.IL-13Rα2 介导的 IL-13 活性减弱导致 IL10-/- 小鼠结肠炎和肠道炎症。
Gastroenterology. 2011 Jan;140(1):254-64. doi: 10.1053/j.gastro.2010.09.047. Epub 2010 Oct 14.